EUVIMEDEUVIMED entdecken
Open Access

The SPRR2A-CSTA axis drives IL-17A–induced squamous metaplasia and steroid resistance in allergic rhinitis

Shaobing Xie, Xuan Yuan, Liyuan Liu, Maonan Wu, Wenjing Gu, Hua Zhang, Zhihai Xie, Weihong Jiang, Peisong Gao

Journal of Allergy and Clinical Immunology · 2026-10 · 158 (4) · 994-1009.e8

DOI: 10.1016/j.jaci.2026.05.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-10. Verfasst von Shaobing Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Md; Department of Otolaryngology Head and Neck S…. Hauptthemen laut MEDLINE: Cornified Envelope Proline-Rich Proteins, Interleukin-17, Rhinitis, Allergic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Epithelial remodeling, particularly squamous metaplasia (SM), is a common but understudied epithelial alteration in refractory allergic rhinitis (AR). Its molecular drivers and contribution to steroid resistance remain unclear. OBJECTIVE: We sought to define the epithelial keratinization program underlying SM in AR and determine its role in glucocorticoid resistance. METHODS: Nasal mucosa tissues from patients with refractory AR with or without SM were assessed by immunostaining and transcriptomic profiling. Small proline-rich protein 2A (SPRR2A)-deficient mice were used to determine the role of SPRR2A in epithelial keratinization and steroid responsiveness. Primary nasal epithelial cells were stimulated with IL-17A or cystatin A (CSTA) to evaluate SPRR2A-dependent keratinization and steroid resistance. Serum SPRR2A and CSTA levels were quantified in patients with AR stratified by steroid responsiveness. RESULTS: Transcriptomic analysis identified SPRR2A as a leading epithelial marker associated with SM in AR. SPRR2A-associated keratin remodeling, including upregulation of KRT6A and KRT13, represented a defining molecular signature of SM. Glucocorticoid receptor β, a key mediator of steroid resistance, was markedly increased and colocalized with KRT6A and KRT13 in SM tissues. IL-17A induced a robust SPRR2A-keratin remodeling module, generating a steroid-resistant epithelial state. Genetic deletion of Sprr2a abolished IL-17A-driven keratinization, prevented SM, and restored steroid responsiveness. Mechanistically, CSTA emerged as a SPRR2A-dependent effector that promoted squamous differentiation and epithelial GRβ induction. Csta-treated primary cultures recapitulated SM and conferred steroid resistance. Clinically, elevated serum SPRR2A and CSTA levels distinguished patients with steroid-resistant AR from those with steroid-responsive AR. CONCLUSIONS: SPRR2A promotes epithelial SM and steroid resistance through CSTA, identifying the SPRR2A-CSTA axis as a potential therapeutic target and biomarker pathway in refractory AR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cornified Envelope Proline-Rich ProteinsInterleukin-17Rhinitis, AllergicAnimalsHumansMetaplasiaMiceDrug ResistanceFemaleNasal MucosaMice, KnockoutMale

Stichwörter der Autor:innen

Allergic rhinitiscystatin Asmall proline-rich protein 2Asquamous metaplasiasteroid resistance

Substanzen

Cornified Envelope Proline-Rich ProteinsInterleukin-17IL17A protein, human

Autor:innen und Institutionen

  • Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Md; Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital of Central South University, Changsha, Hunan,…
  • Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Md.
  • Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Md; Department of Pediatric Respiratory Medicine, Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Md; Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital of Central South University, Changsha, Hunan, China; Hunan Province Key Laboratory of Otolaryngology Critical Diseases, Xiangya Hospital of Central So…
  • Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: pgao1@jhmi.edu.

Förderung

  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Xie, S., Yuan, X., Liu, L., Wu, M., Gu, W., Zhang, H., Xie, Z., Jiang, W., & Gao, P. (2026). The SPRR2A-CSTA axis drives IL-17A–induced squamous metaplasia and steroid resistance in allergic rhinitis. Journal of Allergy and Clinical Immunology, 158(4), 994-1009.e8. https://doi.org/10.1016/j.jaci.2026.05.024

Vancouver

Xie S, Yuan X, Liu L, Wu M, Gu W, Zhang H, et al. The SPRR2A-CSTA axis drives IL-17A–induced squamous metaplasia and steroid resistance in allergic rhinitis. Journal of Allergy and Clinical Immunology. 2026;158(4):994-1009.e8. doi:10.1016/j.jaci.2026.05.024

BibTeX
@article{Xie2026,
  author = {Xie, Shaobing and Yuan, Xuan and Liu, Liyuan and Wu, Maonan and Gu, Wenjing and Zhang, Hua and Xie, Zhihai and Jiang, Weihong and Gao, Peisong},
  title = {The SPRR2A-CSTA axis drives IL-17A–induced squamous metaplasia and steroid resistance in allergic rhinitis},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2026},
  volume = {158},
  number = {4},
  pages = {994--1009.e8},
  doi = {10.1016/j.jaci.2026.05.024}
}
Kostenlos starten →